Chloraprep one-step and Urticaria aggravated - a phase IV clinical study of FDA data

Summary:

Urticaria aggravated is reported as a side effect among people who take Chloraprep one-step (chlorhexidine gluconate; isopropyl alcohol), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Simponi, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Urticaria aggravated when taking Chloraprep one-step. It is created by eHealthMe based on reports of 581 people who have side effects when taking Chloraprep one-step from the FDA, and is updated regularly.

What is Chloraprep one-step?

Chloraprep one-step has active ingredients of chlorhexidine gluconate; isopropyl alcohol. eHealthMe is studying from 582 Chloraprep one-step users. Check the latest studies of Chloraprep one-step.

What is Urticaria aggravated?

Urticaria aggravated (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,058 drugs and 723 conditions by eHealthMe. Check the latest studies of Urticaria aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

581 people reported to have side effects when taking Chloraprep one-step.
Among them, 171 people (29.43%) have Urticaria aggravated.

Could Chloraprep one-step cause Urticaria aggravated?

Among these 171 people:

How long have people been on Chloraprep one-step when they have Urticaria aggravated? *

Click here to view more results

What is the gender of people who have Urticaria aggravated when taking Chloraprep one-step? *

Click here to view

What is the age of people who have Urticaria aggravated when taking Chloraprep one-step? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Chloraprep one-step and have Urticaria aggravated?

- Check whether Urticaria aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Chloraprep one-step:

Chloraprep one-step (582 reports)

Urticaria aggravated treatments and more:

Urticaria aggravated (77 reports)

How severe was Urticaria aggravated and when was it recovered:

Urticaria aggravated in Chloraprep one-step

Expand to all the drugs that have ingredients of chlorhexidine gluconate; isopropyl alcohol:

Urticaria aggravated and drugs with ingredients of chlorhexidine gluconate; isopropyl alcohol

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Chloraprep one-step:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria aggravated:

Urticaria aggravated (2,058 drugs)

Browse all the conditions that are associated with Urticaria aggravated:

Urticaria aggravated (723 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on chlorhexidine gluconate; isopropyl alcohol (the active ingredients of Chloraprep one-step) and Chloraprep one-step (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.